Trillium Therapeutics Inc. (TRIL): Price and Financial Metrics

Trillium Therapeutics Inc. (TRIL)

Today's Latest Price: $14.35 USD

0.46 (-3.11%)

Updated Oct 19 9:50pm

Add TRIL to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 240 in Medical - Pharmaceuticals

See all "A" rated Strong Buy stocks

TRIL Stock Price Chart Interactive Chart >

Price chart for TRIL

TRIL Price/Volume Stats

Current price $14.35 52-week high $16.89
Prev. close $14.81 52-week low $0.24
Day low $14.25 Volume 1,276,900
Day high $15.14 Avg. volume 3,049,065
50-day MA $12.56 Dividend yield N/A
200-day MA $7.27 Market Cap 1.41B

Trillium Therapeutics Inc. (TRIL) Company Bio

Trillium Therapeutics develops therapies for the treatment of cancer. The company was founded in 2004 and is based in Toronto, Canada.

TRIL Latest News Stream

Event/Time News Detail
Loading, please wait...

TRIL Latest Social Stream

Loading social stream, please wait...

View Full TRIL Social Stream

Latest TRIL News From Around the Web

Below are the latest news stories about Trillium Therapeutics Inc that investors may wish to consider to help them evaluate TRIL as an investment opportunity.

Market Crash 2020: The Next Drop Will Be Much Worse

Stock markets remain shaky despite the dramatic rebound following the March crash. However, a sequel could be worse. Only the Trillium Therapeutics stock seems to be defying the pandemic. Analysts see explosive growth down the road. The post Market Crash 2020: The Next Drop Will Be Much Worse appeared first on The Motley Fool Canada .

The Motley Fool Canada | September 26, 2020

The Daily Biotech Pulse: Marinus Epilepsy Study Meets Goal, Novavax Reaches Vaccine Manufacturing Deal, Outset Medical's IPO

Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 14) 10X Genomics Inc (NASDAQ: TXG ) Applied Molecular Transport Inc. (NASDAQ: AMTI ) Avenue Therapeutics Inc (NASDAQ: ATXI ) Avidity Biosciences Inc (NASDAQ: RNA ) BioLife Solutions Inc (NASDAQ: BLFS ) Denali Therapeutics Inc (NASDAQ: DNLI ) Guardant Health Inc (NASDAQ: GH ) Immunomedics, Inc. (NASDAQ: IMMU ) - announced a deal to be bought by Gilead Sciences, Inc. (NASDAQ: GILD ) for $21 billion Inspire Medical Systems Inc (NYSE: INSP ) Kintara Therapeutics Inc (NASDAQ: KTRA ) Kura Oncology Inc (NASDAQ: KURA ) Nurix Therapeutics Inc (NASDAQ: NRIX ) Pacific Biosciences of California Inc (NASDAQ: PACB ) (announced the appointment of Susan Kim as CFO, effective Sept. 28) Shockwave Medical Inc (NASDAQ: SWAV ) SI-Bone Inc (NASDAQ...

Benzinga | September 15, 2020

Trillium prices equity offering at $13

Trillium Therapeutics (TRIL) has priced its public offering of 10M common shares at $13.00/share, for expected gross proceeds of ~$130M. Underwriters' over-allotment is an additional 1.5M shares. Net proceeds will be used for ongoing and planned clinical trials for CD47 program, for working capital and general corporate purposes.Closing date is...

Seeking Alpha | September 11, 2020

The Daily Biotech Pulse: Positive Readout From Galapagos, Intersect ENT Strikes Distribution Deal, Sol Gel's Regulatory Filing Accepted For Review

Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 10) Agenus Inc (NASDAQ: AGEN ) Akouos Inc (NASDAQ: AKUS ) BioLife Solutions Inc (NASDAQ: BLFS ) Checkpoint Therapeutics Inc (NASDAQ: CKPT ) ESSA Pharma Inc (NASDAQ: EPIX ) Fortress Biotech (NASDAQ: FBIO ) Harmony Biosciences Holdings Inc (NASDAQ: HRMY ) Inspire Medical Systems Inc (NYSE: INSP ) Kintara Therapeutics Inc (NASDAQ: KTRA ) Kura Oncology Inc (NASDAQ: KURA ) Protagonist Therapeutics Inc (NASDAQ: PTGX ) RedHill Biopharma Ltd (NASDAQ: RDHL ) Silk Road Medical Inc (NASDAQ: SILK ) Shockwave Medical Inc (NASDAQ: SWAV ) Trillium Therapeutics Inc (NASDAQ: TRIL ) Down In The Dumps (Biotech Stocks Hitting 52-week Lows Sept. 10) ADiTx Therapeutics Inc (NASDAQ: ADTX ) AnPac Bio-Medical Science Co Ltd – ADR (NASDAQ: ANPC )(reac...

Benzinga | September 11, 2020

Trillium launches 8.5M-share stock offering

Trillium (TRIL) commences a public offering of 8.5M common shares. Price and terms have yet to be announced.Shares down 4% after hours....

Seeking Alpha | September 9, 2020

Read More 'TRIL' Stories Here

TRIL Price Returns

1-mo -10.31%
3-mo 72.48%
6-mo 188.73%
1-year 4,766.06%
3-year 100.70%
5-year 7.81%
YTD 1,293.20%
2019 -39.77%
2018 -76.41%
2017 28.32%
2016 -55.19%
2015 40.11%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.7139 seconds.